key: cord-0755872-n0sknb7y
authors: Mesnil, Malcie; Joubel, Kevin; Yavchitz, Amélie; Miklaszewski, Nicolas; Devys, Jean-Michel
title: Seroprevalence of SARS-Cov-2 in 646 professionals at the Rothschild Foundation Hospital (ProSeCoV study)
date: 2020-08-27
journal: Anaesth Crit Care Pain Med
DOI: 10.1016/j.accpm.2020.08.003
sha: 3a4d967c14451549f0b47e60415dc5b20d4f1d9c
doc_id: 755872
cord_uid: n0sknb7y

nan

March 16 and April 19, 2020. Sixty-eight patients were managed in Intensive Care Units (ICU) cr, thanks to an increase in ICU bed capacity from 10 to 39 beds. The Rothschild Foundation Hospital decided to offer SARS-CoV-2 IgG serology (ELISA technique, Elecsys® Anti-SARS-CoV-2 Roche COBAS 6000) to all volunteer employees, HCW and non-HCW. As the seroconversion rate following an infection is 90% to 100% after the third week following the contamination, 1 blood samples were organised 4 weeks after the end of the French lockdown (June 8 to June 22). In this context, the ProSeCov study aimed at evaluating the effectiveness of the prevention of occupational contamination by analysing the seroprevalence rate for SARS-CoV-2. The sampling was coupled with a questionnaire concerning personal history with COVID-19, risk factors for serious forms and working conditions. The results were used anonymously. According to the French law, the study was considered to be in compliance with the MR-004 conditions 2, and was approved by the J o u r n a l P r e -p r o o f institution's ethics committee (CE_20200721_10_MML). The workers were informed of the study and could refuse to participate. Fisher's exact test was used when appropriate.

Six hundred and forty-six samples associated with a questionnaire were collected (58% of the establishment's employees). Mains results are summarised in Figure 1 . Seventy-eight out of 646 samples had positive serology (12.1%). There was no difference in the seroconversion of HCW versus administrative workers and between HCW from COVID-19 and non-COVID-19 units. Although more exposed, HCW seroconversion was similar to that of administrative workers.

In the same way, the seroconversion was similar in COVID-19 and non-COVID-19 HCW. 

Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)

French legal approach to clinical research

Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital

Dynamic of SARS-CoV-2 RT-PCR positivity and seroprevalence among high-risk health care workers and hospital staff

Prevalence of SARS-CoV-2 Antibodies in Health Care Personnel in the New York City Area